Brilliant Violet 570a,,cents anti-mouse CD62L [MEL-14] and 8 more items

BioLegend Inc. has been awarded a purchase order (PO-0482237) by the University of Virginia, a contracting organization located in Virginia, effective September 19, 2026. The cumulative contract value is $2,126.20. The order encompasses nine distinct laboratory reagent products, specifically monoclonal antibodies conjugated with various fluorescent markers used for flow cytometry applications. These include anti-mouse antibodies targeting cell surface antigens such as CD62L, CD279 (Programmed Death-1), CD21/CD35, CD196, CD19, CD40, CD186, and CD274 (Programmed Death-Ligand 1), with quantities ranging from one to two units per item. All materials are designated for delivery to Melissa A Marshall at the University of Virginia.

The contract represents a supply procurement of research-grade immunological reagents consistent with academic laboratory operations. Unit prices for individual items range from $46.20 to $246.40, with the composition and specifications of each antibody product detailed in the respective line item descriptions. This award supports the University of Virginia's research infrastructure and immunological studies requiring flow cytometric analysis capabilities.